Literature DB >> 19905962

Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.

Olle Ringdén.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19905962     DOI: 10.1089/scd.2009.1809.edi

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


× No keyword cloud information.
  4 in total

1.  Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells.

Authors:  Shyam A Patel; Pranela Rameshwar
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09-01

2.  Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model.

Authors:  Leland Metheny; Saada Eid; Karen Lingas; Racheli Ofir; Lena Pinzur; Howard Meyerson; Hillard M Lazarus; Alex Y Huang
Journal:  Front Med (Lausanne)       Date:  2018-02-22

Review 3.  Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia.

Authors:  Vivian Fonseca Gonzaga; Cristiane Valverde Wenceslau; Gustavo Sabino Lisboa; Eduardo Osório Frare; Irina Kerkis
Journal:  Stem Cells Int       Date:  2017-12-03       Impact factor: 5.443

4.  Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.

Authors:  Olle Ringdén; Britt Gustafsson; Behnam Sadeghi
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.